The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF

Developmental Biology

Volumn 211, Issue 2, 1999, Pages 255-267

  Bi, Weizhen ^a   Drake, Christopher J ^b   Schwarz, John J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiopoietin 1; Cardiovascular development; MEF2; VEGF

Indexed keywords

ANGIOPOIETIN 1; CYTOKINE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEF2C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; EMBRYO; ENDOCARDIUM; HEART DEVELOPMENT; HEART MUSCLE; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; YOLK SAC;

ANIMALIA;

EID: 0033566045     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1999.9307     Document Type: Article

References (53)

1. Achen M. G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. 95:1998;548-553.
2. Benjamin L. E., Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA. 94:1997;8761-8766.
3. Bour B. A., O'Brien M. A., Lockwood W. L., Goldstein E. S., Bodmer R., Taghert P. H., Abmayr S. M., Nguyen H. T. Drosophila MEF2, and transcription factor that is essential for myogenesis. Genes Dev. 9:1995;730-741.
4. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996a;435-439.
5. Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Vlaenderen I. V., Demunck H., Kasper M., Breier G., Evrard P., Muller M., Risau W., Edgington T., Collen D. Role of tissue factor in embryonic blood vessel development. Nature. 383:1996b;73-75.
6. Chen J.-N., Haffter P., Odenthal J., Vogelsang E., Brand M., Van Eeden F. J. M., Furutani-Seiki M., Granato M., Hammerschmidt M., Heisenberg C.-P., Jiang Y.-J., Kane D. A., Kelsh R. N., Mullins M. C., Nusslein-Volhard C. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development. 123:1996;293-302.
7. Choi D.-S., Ward S. J., Messaddeq N., Launay J.-M., Maroteaux L. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardial cells. Development. 124:1997;1745-1755.
8. Choi K., Kennedy M., Kazarov A., Papadimitriou J. C., Keller G. A common precursor for hematopoietic and endothelial cells. Development. 125:1998;725-732.
9. Connolly A. J., Ishihara H., Kahn M. L., Farese R. V., Coughlin S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 381:1996;516-519.
10. Dickson M. C., Martin J. S., Cousins F. M., Kulkarni A. B., Karlsson S., Akhurst R. J. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 121:1995;1845-1854.
11. Drake C. J., Little C. D. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA. 92:1995;7657-7661.
12. Drake C. J., Brandt S. J., Trusk T. C., Little C. D. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol. 192:1997;17-30.
13. Drake C. J., Hungerford J. E., Little C. D. Morphogenesis of the first blood vessels. Fleischmajer R., Timpi R., Werb Z. Annals of the New York Academy of Science Morphogenesis: Cellular Interactions. 1998;155-180 New York Academy of Science, New York.
14. Dumont D. J., Gradwohl G., Fong G.-H., Puri M. C., Gertsenstein M., Auerbach A., Breitman M. L. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1994;1897-1909.
15. Eichmann A., Corbel C., Nataf V., Vaigot P., Breant C., Le Douarin N. M. Ligand-dependent development of the endothelial and hemapoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl. Acad. Sci. USA. 94:1997;5141-5146.
16. Edmondson D. G., Lyons G. E., Martin J. F., Olson E. N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 120:1994;1251-1263.
17. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
18. Firulli A. B., Miano J. M., Bi W., Johnson A. D., Casscells W., Olson E. N., Schwarz J. J. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells: Association with the activated phenotype. Circ. Res. 78:1996;196-204.
19. Flamme I., von Reutern M., Drexler H. C. A., Syed-Ali S., Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev. Biol. 171:1995;399-414.
20. Fong G.-H., Rossant J., Gertsenstein M., Breitman M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
21. Gessner I. H. Spectrum of congenital cardiac anomalies produced in chick embryos by mechanical interference with cardiogenesis. Circ. Res. 18:1966;625-632.
22. Han J., Jiang Y., Li Z., Kravchenko V. V., Ulevitch R. J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296-299.
23. Henkemeyer M., Rossi D. J., Holmyard D. P., Puri M. C., Mbamalu G., Harpal K., Shih T. S., Jacks T., Pawson T. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature. 377:1995;695-701.
24. Hogers B., DeRuiter M. C., Gittenberger-de Groot A. C., Poelmann R. E. Unilateral vitilline vein ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ. Res. 80:1996;473-481.
25. 2 homeostasis by hypoxia-inducible factor 1α Genes Dev. 12:1998;149-162.
26. Kato Y., Kravchenko V. V., Tapping R. I., Han J., Ulevitch R. J., Lee J. D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:1997;7054-7066.
27. Kull E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V., Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development. 122:1996;3829-3837.
28. Lilly B., Zhao B., Ranganayakulu G., Paterson B. M., Shulz R. A., Olson E. N. Requirement of MADS domain transcription factor d-MEF2 for muscle formation in Drosophila. Science. 267:1995;688-693.
29. Lin Q., Schwarz J. J., Olson E. N. Control of cardiac morphogenesis and myogenesis by the myogenic transcription factor MEF2C. Science. 276:1997;1404-1407.
30. Lin Q., Lu J., Yanagisawa H., Webb R., Lyons G. E., Richardson J. A., Olson E. N. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 125:1998;4565-4574.
31. Lindahl P., Johansson B. R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:1997;242-245.
32. Lyons G. E., Micales B. K., Schwarz J., Martin J. F., Olson E. N. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15:1995;5727-5738.
33. Maisonpierre P. C., Suri C., Jones P., Bartunkova S., Wiengand S., Radziejewski C., Compton D., McClain J., Aldrich T., Papadopoulos N., Daly T., Davis S., Sato T., Yancopoulos G. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
34. Martin J. F., Schwarz J. J., Olson E. N. Myocyte enhancer factor (mef) 2c: A tissue-restricted member of the mef-2 family of transcription factors. Proc. Natl. Acad. Sci. USA. 90:1993;5282-5286.
35. McDermott J. C., Cardoso M. C., Yu Y. T., Andres V., Leifer D., Krainc D., Lipton S. A., Nadal-Ginard B. Hmef2c gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:1993;2564-2577.
36. Offermanns S., Mancino V., Revel J. P., Simon M. I. Vascular system defects and impaired cell chemokinesis as a result of Gα13 deficiency. Science. 275:1997;533-536.
37. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R. F., Alitalo K., Eriksson U. Proc. Natl. Acad. Sci. USA. 93:1996;2576-2581.
38. Olson E. N., Perry M., Schulz R. A. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172:1995;2-14.
39. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
40. Risau W., Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:1995;73-91.
41. Ryan H. E., Lo J., Johnson R. S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:1998;3005-3015.
42. Sato T. N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases tie-1 and tie-2 in blood vessel formation. Nature. 376:1995;70-74.
43. Schlaeger T. M., Qin Y., Fujiwara Y., Magram J., Sato T. N. Vascular endothelial cell lineage-specific promoter in transgenic mice. Development. 121:1995;1089-1098.
44. Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X.-F., Breitman M. L., Schuh A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
45. Soker S., Takashima S., Miao H. Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
46. Springer M. L., Chen A. S., Kraft P. E., Bednarski M., Blau H. M. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol. Cell. 2:1998;549-558.
47. Stainier D. Y. R., Fouquet B., Chen J.-N., Warren K. S., Weinstein B. M., Meiler S. E., Mohideen M.-A., Neuhauss S. C. F., Solnica-Krezel L., Schier A. F., Zwartkruis F., Stemple D. L., Malicki J., Driever W., Fishman M. C. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 123:1996;285-292.
48. Stainier, D. Y. R., Weinstein, B. M., Detrich, H. W., Zon, L. I., and Fishman, M. C. (195). Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development121, 3141-3150.
49. Suri C., Jones P. F., Patan S., Bartunkova S., Maisonpierre P. C., Davis S., Sato T. N., Yancopoulos G. D. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
50. Swanson B. J., Jack H. M., Lyons G. E. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. Mol. Immunol. 35:1998;445-458.
51. Tian H., McKnight S. L., Russell D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:1997;72-82.
52. Visvader J. E., Fujiwara Y., Orkin S. H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:1998;473-479.
53. Wang H. U., Chen Z.-F., Anderson D. J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:1998;741-753.